Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial. - Sundén-Cullberg, Jonas; Chen, Puran; Häbel, Henrike; Skorup, Paul; Janols, Helena; Rasmuson, Johan; Niward, Katarina; Östholm Balkhed, Åse; Chatzidionysiou, Katerina; Asgeirsson, Hilmir; Blennow, Ola; Parke, Åsa; et al. (PLoS ONE, 2023)